Dihydroartemisinin protects blood–brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1

Blood–brain barrier (BBB) injury is involved in the pathogenesis of sepsis‐associated encephalopathy. In this study, we used dihydroartemisinin (DHA), a derivative of artemisinin, to treat a cecal ligation and puncture (CLP)‐induced mouse sepsis model and a tumour necrosis factor α (TNF‐α)‐stimulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fuhong, Liu, Jing, Xiang, Hongjie, Sun, Zongguo, Li, Yan, Li, Xiao, Liu, Yanjun, Liu, Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543489/
https://www.ncbi.nlm.nih.gov/pubmed/35651290
http://dx.doi.org/10.1111/1440-1681.13683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543489/
https://www.ncbi.nlm.nih.gov/pubmed/35651290
http://dx.doi.org/10.1111/1440-1681.13683

Ejemplares similares